The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.
clinical trials
Posted inNPR
The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency’s website, as the Trump administration halts DEI initiatives.
Posted inNPR
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.
